Cat eye syndrome: Clinical, cytogenetics and familial findings in a large cohort of 43 patients highlighting the importance of congenital heart disease and inherited cases.

22q11.2 region FISH array-CGH cat eye syndrome congenital heart disease eye anomalies familial disease heart defect mosacism parental transmission small supernumerary marker chromosome (sSMC)

Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
16 Nov 2023
Historique:
revised: 13 10 2023
received: 22 07 2023
accepted: 05 11 2023
pubmed: 17 11 2023
medline: 17 11 2023
entrez: 17 11 2023
Statut: aheadofprint

Résumé

Cat Eye Syndrome (CES) is a rare genetic disease caused by the presence of a small supernumerary marker chromosome derived from chromosome 22, which results in a partial tetrasomy of 22p-22q11.21. CES is classically defined by association of iris coloboma, anal atresia, and preauricular tags or pits, with high clinical and genetic heterogeneity. We conducted an international retrospective study of patients carrying genomic gain in the 22q11.21 chromosomal region upstream from LCR22-A identified using FISH, MLPA, and/or array-CGH. We report a cohort of 43 CES cases. We highlight that the clinical triad represents no more than 50% of cases. However, only 16% of CES patients presented with the three signs of the triad and 9% not present any of these three signs. We also highlight the importance of other impairments: cardiac anomalies are one of the major signs of CES (51% of cases), and high frequency of intellectual disability (47%). Ocular motility defects (45%), abdominal malformations (44%), ophthalmologic malformations (35%), and genitourinary tract defects (32%) are other frequent clinical features. We observed that sSMC is the most frequent chromosomal anomaly (91%) and we highlight the high prevalence of mosaic cases (40%) and the unexpectedly high prevalence of parental transmission of sSMC (23%). Most often, the transmitting parent has mild or absent features and carries the mosaic marker at a very low rate (<10%). These data allow us to better delineate the clinical phenotype associated with CES, which must be taken into account in the cytogenetic testing for this syndrome. These findings draw attention to the need for genetic counseling and the risk of recurrence.

Identifiants

pubmed: 37974505
doi: 10.1002/ajmg.a.63476
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Bélien, V., Gérard-Blanluet, M., Serero, S., le Dû, N., Baumann, C., Jacquemont, M. L., Dupont, C., Krabchi, K., Drunat, S., Elbez, A., Janaud, J. C., Benzacken, B., Verloes, A., Tabet, A. C., & Aboura, A. (2008). Partial trisomy of chromosome 22 resulting from a supernumerary marker chromosome 22 in a child with features of cat eye syndrome. American Journal of Medical Genetics. Part A, 146A(14), 1871-1874.
Berends, M. J., Tan-Sindhunata, G., Leegte, B., & van Essen, A. J. (2001). Phenotypic variability of cat-eye syndrome. Genet Couns, 12(1), 23-34.
Gaspar, N. S., Rocha, G., Grangeia, A., & Soares, H. C. (2022). Cat-eye syndrome: A report of two cases and literature review. Cureus, 14(6), e26316.
Jedraszak, G., Braun, K., Receveur, A., Decamp, M., Andrieux, J., Rabbind Singh, A., Copin, H., Bremond-Gignac, D., Mathieu, M., Rochette, J., & Morin, G. (2015). Growth hormone deficiency and pituitary malformation in a recurrent cat-eye syndrome: A family report. Annales d'Endocrinologie, 76(5), 629-634.
Karcaaltincaba, D., Ceylaner, S., Ceylaner, G., Dalkilic, S., Karli-Oguz, K., & Kandemir, O. (2010). Partial trisomy due to a de novo duplication 22q11.1-22q13.1: A cat-eye syndrome variant with brain anomalies. Genet Couns, 21(1), 19-24.
Kekunnaya, R., & Negalur, M. (2017). Duane retraction syndrome: Causes, effects and management strategies. Clinical Ophthalmology, 11, 1917-1930.
Knijnenburg, J., van Bever, Y., Hulsman, L. O. M., van Kempen, C. A. P., Bolman, G. M., van Loon, R. L. E., Beverloo, H. B., & van Zutven, L. J. C. M. (2012). A 600 kb triplication in the cat eye syndrome critical region causes anorectal, renal and preauricular anomalies in a three-generation family. European Journal of Human Genetics, 20(9), 986-989.
Kvarnung, M., Lindstrand, A., Malmgren, H., Thåström, A., Jacobson, L., Dahl, N., Lundin, J., & Blennow, E. (2012). Inherited mosaicism for the supernumerary marker chromosome in cat eye syndrome: Inter- and intra-individual variation and correlation to the phenotype. American Journal of Medical Genetics, 158A(5), 1111-1117.
Liehr, T. (2006). Familial small supernumerary marker chromosomes are predominantly inherited via the maternal line. Genetics in Medicine, 8(7), 459-462.
Lüleci, G., Bağci, G., Kivran, M., Lüleci, E., Bektaş, S., & Başaran, S. (1989). A hereditary bisatellite-dicentric supernumerary chromosome in a case of cat-eye syndrome. Hereditas, 111(1), 7-10.
McTaggart, K. E., Budarf, M. L., Driscoll, D. A., Emanuel, B. S., Ferreira, P., & McDermid, H. E. (1998). Cat eye syndrome chromosome breakpoint clustering: Identification of two intervals also associated with 22q11 deletion syndrome breakpoints. Cytogenetics and Cell Genetics, 81(3-4), 222-228.
Mears, A. J., el- Shanti, H., Murray, J. C., McDermid, H. E., & Patil, S. R. (1995). Minute supernumerary ring chromosome 22 associated with cat eye syndrome: Further delineation of the critical region. American Journal of Human Genetics, 57(3), 667-673.
Melo, C., Gama-de-Sousa, S., Almeida, F., Rendeiro, P., Tavares, P., Cardoso, H., & Carvalho, S. (2013). Cat eye syndrome and growth hormone deficiency with pituitary anomalies: A case report and review of the literature. Gene, 529(1), 186-189.
Rosias, P. R., Sijstermans, J. M., Theunissen, P. M., Pulles-Heintzberger, C. F., de Die-Smulders, C. E., Engelen, J. J., & van der Meer, S. (2001). Phenotypic variability of the cat eye syndrome. Case report and review of the literature. Genet Couns, 12(3), 273-282.
Schachenmann, G., Schmid, W., Fraccaro, M., Mannini, A., Tiepolo, L., Perona, G., & Sartori, E. (1965). Chromosomes in coloboma and anal atresia. Lancet, 2(7406), 290.
Serra, G., Giambrone, C., Antona, V., Cardella, F., Carta, M., Cimador, M., Corsello, G., Giuffrè, M., Insinga, V., Maggio, M. C., Pensabene, M., Schierz, I. A. M., & Piro, E. (2022). Congenital hypopituitarism and multiple midline defects in a newborn with non-familial cat eye syndrome. Ital. The Journal of Pediatrics, 48(1), 170.
Urioste, M., Visedo, G., Sanchís, A., Sentís, C., Villa, A., Ludeña, P., Hortigüela, J. L., Martínez-Frías, M. L., & Fernández-Piqueras, J. (1994). Dynamic mosaicism involving an unstable supernumerary der(22) chromosome in cat eye syndrome. American Journal of Medical Genetics, 49(1), 77-82.
Williams, J. L., McDonald, M. T., Seifert, B. A., Deak, K. L., Rehder, C. W., & Campbell, M. J. (2021). An unusual association: Total anomalous pulmonary venous return and aortic arch obstruction in patients with cat eye syndrome. Journal of Pediatric Genetics, 10(1), 35-38.

Auteurs

Guillaume Jedraszak (G)

Constitutional Genetics Laboratory, University Hospital of Amiens, Amiens, France.
UR4666, University of Picardy Jules Verne, Amiens, France.

Florence Jobic (F)

Clinical Genetics Unit, University Hospital of Amiens, Amiens, France.

Aline Receveur (A)

Constitutional Genetics Laboratory, University Hospital of Amiens, Amiens, France.

Frédéric Bilan (F)

Genetics Laboratory, University Hospital of Poitiers, Poitiers, France.

Brigitte Gilbert-Dussardier (B)

Medical Genetics Unit, University Hospital of Poitiers, Poitiers, France.

Busa Tiffany (B)

Medical Genetics Unit, University Hospital of Marseille, Marseille, France.

Chantal Missirian (C)

Cytogenetics Laboratory, University Hospital of Marseille, Marseille, France.

Marjolaine Willems (M)

Medical Genetics Laboratory, University Hospital of Montpellier, Montpellier, France.

Sylvie Odent (S)

Medical Genetics Unit, University Hospital of Rennes, Rennes, France.

Josette Lucas (J)

Genetics Laboratory, University Hospital of Rennes, Rennes, France.

Christele Dubourg (C)

Molecular & Genomic Institute, Rennes, France.

Elise Schaefer (E)

Clinical Genetics Unit, University Hospital of Strasbourg, Strasbourg, France.

Sophie Scheidecker (S)

Medical Genetics Laboratory & INSERM U1112, Strasbourg, France.

James Lespinasse (J)

Clinical Genetics Unit, Hospital of Chambéry, Chambéry, France.

Alice Goldenberg (A)

Clinical Genetics Unit, University Hospital of Rouen, Rouen, France.

Anne-Marie Guerrot (AM)

Clinical Genetics Unit, University Hospital of Rouen, Rouen, France.

Géraldine Joly-Helas (G)

Cytogenetics Laboratory, University Hospital of Rouen, Rouen, France.

Pascal Chambon (P)

Cytogenetics Laboratory, University Hospital of Rouen, Rouen, France.

Cédric Le Caignec (C)

Medical Gentics Unit, University Hospital of Toulouse, Toulouse, France.

Albert David (A)

Clinical Genetics Unit, University Hospital of Nantes, Nantes, France.

Charles Coutton (C)

Cytogenetics Laboratory, University Hospital of Grenoble & INSERM U1209 Institute for Advanced Biosciences, University of Grenoble Alpes, Grenoble, France.

Véronique Satre (V)

Cytogenetics Laboratory, University Hospital of Grenoble & INSERM U1209 Institute for Advanced Biosciences, University of Grenoble Alpes, Grenoble, France.

Gaëlle Vieville (G)

Cytogenetics Laboratory, University Hospital of Grenoble, Grenoble, France.

Florence Amblard (F)

Cytogenetics Laboratory, University Hospital of Grenoble, Grenoble, France.

Radu Harbuz (R)

Cytogenetics Laboratory, University Hospital of Grenoble, Grenoble, France.

Damien Sanlaville (D)

Cytogenetics Laboratory, University Hospital of Lyon, Bron, France.

Marianne Till (M)

Cytogenetics Laboratory, University Hospital of Lyon, Bron, France.

Catherine Vincent-Delorme (C)

Catherine Vincent Delorme, Clinical Genetics Unit Guy Fontaine, University Hospital of Lille, Lille, France.

Cindy Colson (C)

Catherine Vincent Delorme, Clinical Genetics Unit Guy Fontaine, University Hospital of Lille, Lille, France.

Joris Andrieux (J)

Molecular Genetics Institute, University hospital of Lille, Lille, France.

Sophie Naudion (S)

Clinical Genetics Unit, University Hospital of Bordeaux, Bordeaux, France.

Jérome Toutain (J)

Clinical Genetics Unit, University Hospital of Bordeaux, Bordeaux, France.

Caroline Rooryck (C)

Medical Genetics Laboratory, University Hospital of Bordeaux, Bordeaux, France.

Bénédicte de Fréminville (B)

Genetics Laboratory, University Hospital of Saint-Etienne, Saint-Etienne, France.

Fabienne Prieur (F)

Medical Genetics Unit, University Hospital of Saint-Etienne, Saint Etienne, France.

Valérie Cormier Daire (VC)

Medical Genetics Federation, Necker-Children's Hospital, Paris, France.

Daniel Amram (D)

Clinicial Genetics Unit, University Hospital of Creteil, Creteil, France.

Pascale Kleinfinger (P)

Cerba Laboratory, Saint-Ouen, France.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

Gisela Raabe-Meyer (G)

Praxis für Humangenetik Dr. Schulze, Hannover, Germany.

Carolina Courage (C)

Folkhälsan Research Center, Helsinki, Finland.

Johannes Lemke (J)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Eunice G Stefanou (EG)

Cytogenetics Unit, Laboratory of Medical Genetics, University General Hospital of Patras, Patras, Greece.

Thomaidis Loretta (T)

Developmental Assessment Unit, National and Kapodistrian University of Athens, Athens, Greece.

Manolakos Emmanouil (M)

ATG Genetic Center, Athens, Greece.

Sophia Kitsiou Tzeli (SK)

Department of Medical Genetics, National and Kapodistrian University of Athens, Athens, Greece.

Henryka Sodowska (H)

Niepubliczny Zakład Opieki Zdrowotne "Genom", Ruda Slaska, Poland.

Jasen Anderson (J)

Cytogenetics Department, Sullivan and Nicolaides Pathology, Taringa, Queensland, Australia.

Adayapalam Nandini (A)

Department of Cytogenetics, Royal Brisbane and Women's Hospital, Brisbane, Australia.

Henri Copin (H)

Constitutional Genetics Laboratory, University Hospital of Amiens, Amiens, France.

Loïc Garçon (L)

Constitutional Genetics Laboratory, University Hospital of Amiens, Amiens, France.
UR4666, University of Picardy Jules Verne, Amiens, France.

Thomas Liehr (T)

Jena University Hospital, Friedrich Schiller University, Institute of Human Genetics, Jena, Germany.

Gilles Morin (G)

Clinical Genetics Unit, University Hospital of Amiens, Amiens, France.

Classifications MeSH